CSIMarket Company Name, Ticker, Customers, else..
 
Monopar Therapeutics Inc   (NASDAQ: MNPR)
Other Ticker:  
 
 

MNPR's Market share relative to its competitors, as of Q1 2025

As of Q1 2025 (Revenue in Millions of $)

Date modified: 2025-05-18T09:37:37+00:00




 
COMPANY NAME REVENUES
12 Months Ending
Q1 2025		 MARKET SHARE
12 Months
Q1 2025		 MARKET SHARE
MRQ
Q1 2025		 MARKET SHARE
A Quarter Before
Q4 2024
Monopar Therapeutics Inc 0.00 0.00% 0.00 % 0.00 %
Merck and Co Inc 63,922.00 18.83% 18.77% 17.66%
Abbvie Inc 57,367.00 16.90% 16.13% 17.07%
Eli Lilly And Company 49,003.20 14.43% 15.38% 15.30%
Bristol myers Squibb Company 47,636.00 14.03% 13.54% 13.95%
Novartis Ag 46,660.00 13.74% 13.74% 0.00%
Astrazeneca Plc 45,811.00 13.49% 13.49% 0.00%
Regeneron Pharmaceuticals Inc 14,085.70 4.15% 3.66% 4.28%
Vertex Pharmaceuticals Inc 11,099.70 3.27% 3.35% 3.29%
Lantheus Holdings Inc 1,536.15 0.45% 0.45% 0.44%
Supernus Pharmaceuticals inc 668.00 0.20% 0.18% 0.20%
Madrigal Pharmaceuticals Inc 317.38 0.09% 0.17% 0.12%
Intercept Pharmaceuticals inc 288.25 0.08% 0.11% 0.09%
Deciphera Pharmaceuticals Inc 174.91 0.05% 0.05% 0.05%
Macrogenics Inc 154.05 0.05% 0.02% 0.02%
Rhythm Pharmaceuticals inc 136.86 0.04% 0.04% 0.05%
Wave Life Sciences Ltd 104.94 0.03% 0.01% 0.09%
Alimera Sciences Inc 98.09 0.03% 0.03% 0.03%
Zymeworks Inc 93.38 0.03% 0.03% 0.04%
Y mabs Therapeutics inc 88.66 0.03% 0.03% 0.03%
Adc Therapeutics Sa 70.84 0.02% 0.02% 0.02%
Nurix Therapeutics Inc 56.42 0.02% 0.02% 0.02%
Xoma Royalty Corporation 42.91 0.01% 0.02% 0.01%
Mersana Therapeutics inc 34.01 0.01% 0.00% 0.02%
Pliant Therapeutics Inc 9.85 0.00% 0.00% 0.00%
Affimed N v 9.27 0.00% 0.00% 0.00%
Aravive Inc 7.00 0.00% 0.00% 0.00%
Chinook Therapeutics Inc 5.85 0.00% 0.00% 0.00%
Adlai Nortye Ltd 5.00 0.00% 0.00% 0.00%
Salarius Pharmaceuticals inc 4.70 0.00% 0.00% 0.00%
Nuvalent Inc 4.23 0.00% 0.00% 0.00%
I mab 3.89 0.00% 0.00% 0.00%
Bolt Biotherapeutics Inc 3.64 0.00% 0.00% 0.00%
Reata Pharmaceuticals Inc 3.15 0.00% 0.03% 0.00%
Oramed Pharmaceuticals Inc 2.70 0.00% 0.00% 0.00%
Infinity Pharmaceuticals Inc 2.57 0.00% 0.00% 0.00%
Lumos Pharma Inc 2.21 0.00% 0.00% 0.00%
Oncternal Therapeutics Inc 2.16 0.00% 0.00% 0.00%
Ibio inc 2.11 0.00% 0.00% 0.00%
Actinium Pharmaceuticals Inc 1.46 0.00% 0.00% 0.00%
Adagene Inc 0.10 0.00% 0.00% 0.00%
Regenerx Biopharmaceuticals inc 0.08 0.00% 0.00% 0.00%
Merrimack Pharmaceuticals Inc 0.00 0.00% 0.00% 0.00%
Rein Therapeutics Inc 0.00 0.00% 0.00% 0.00%
Corvus Pharmaceuticals Inc 0.00 0.00% 0.00% 0.00%
Milestone Pharmaceuticals inc 0.00 0.00% 0.00% 0.00%
89bio Inc 0.00 0.00% 0.00% 0.00%
Iveric Bio Inc 0.00 0.00% 0.00% 0.00%
Kinnate Biopharma Inc 0.00 0.00% 0.00% 0.00%
Terns Pharmaceuticals Inc 0.00 0.00% 0.00% 0.00%
Mira Pharmaceuticals Inc 0.00 0.00% 0.00% 0.00%
Inhibitor Therapeutics Inc 0.00 0.00% 0.00% 0.00%
Palvella Therapeutics Inc 0.00 0.00% 0.00% 0.00%
Tyme Technologies Inc. 0.00 0.00% 0.00% 0.00%
Nucana Plc 0.00 0.00% 0.00% 0.00%
Effector Therapeutics Inc 0.00 0.00% 0.00% 0.00%
Paxmedica Inc 0.00 0.00% 0.00% 0.00%
Neubase Therapeutics inc 0.00 0.00% 0.00% 0.00%
Phio Pharmaceuticals Corp 0.00 0.00% 0.00% 0.00%
Nextcure Inc 0.00 0.00% 0.00% 0.00%
Whitehawk Therapeutics Inc 0.00 0.00% 0.01% 0.00%
Kineta Inc 0.00 0.00% 0.00% 0.00%
Tempest Therapeutics Inc 0.00 0.00% 0.00% 0.00%
Enliven Therapeutics Inc 0.00 0.00% 0.00% 0.00%
SUBTOTAL 339,519.38 100% 82,735.71 100%



MNPR's Market share relative to its competitors, as of Q1 2025 within the Major Pharmaceutical Preparations Industry
As of Q1 2025



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2025		 MARKET SHARE
12 Months Ending
Q4 2024		 MARKET SHARE
MRQ
Q1 2025		 MARKET SHARE

Q4 2024
Monopar Therapeutics Inc 0.00% 0.00% 0.00 % 0.00 %
Merck and Co Inc 18.91% 19.01% 18.85% 17.74%
Abbvie Inc 16.97% 16.69% 16.20% 17.15%
Eli Lilly And Company 14.50% 13.35% 15.45% 15.37%
Bristol myers Squibb Company 14.09% 14.31% 13.60% 14.02%
Novartis Ag 13.81% 15.36% 13.81% 15.36%
Astrazeneca Plc 13.55% 13.14% 13.55% 13.14%
Regeneron Pharmaceuticals Inc 4.17% 4.21% 3.68% 4.30%
Vertex Pharmaceuticals Inc 3.28% 3.27% 3.36% 3.31%
Supernus Pharmaceuticals inc 0.20% 0.20% 0.18% 0.20%
Madrigal Pharmaceuticals Inc 0.09% 0.00% 0.17% 0.12%
Intercept Pharmaceuticals inc 0.09% 0.08% 0.11% 0.10%
Deciphera Pharmaceuticals Inc 0.05% 0.05% 0.05% 0.05%
Macrogenics Inc 0.05% 0.04% 0.02% 0.02%
Rhythm Pharmaceuticals inc 0.04% 0.04% 0.04% 0.05%
Wave Life Sciences Ltd 0.03% 0.03% 0.01% 0.10%
Alimera Sciences Inc 0.03% 0.03% 0.03% 0.03%
Zymeworks Inc 0.03% 0.02% 0.03% 0.04%
Y mabs Therapeutics inc 0.03% 0.03% 0.03% 0.03%
Adc Therapeutics Sa 0.02% 0.04% 0.02% 0.02%
Nurix Therapeutics Inc 0.02% 0.02% 0.02% 0.02%
Xoma Royalty Corporation 0.01% 0.01% 0.02% 0.01%
Mersana Therapeutics inc 0.01% 0.01% 0.00% 0.02%
Pliant Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Affimed N v 0.00% 0.01% 0.00% 0.01%
Aravive Inc 0.00% 0.00% 0.00% 0.00%
Chinook Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Adlai Nortye Ltd 0.00% 0.00% 0.00% 0.00%
Salarius Pharmaceuticals inc 0.00% 0.00% 0.00% 0.00%
Nuvalent Inc 0.00% 0.00% 0.00% 0.00%
I mab 0.00% 0.00% 0.00% 0.00%
Bolt Biotherapeutics Inc 0.00% 0.00% 0.00% 0.00%
Reata Pharmaceuticals Inc 0.00% 0.00% 0.03% 0.00%
Oramed Pharmaceuticals Inc 0.00% 0.00% 0.00% 0.00%
Infinity Pharmaceuticals Inc 0.00% 0.00% 0.00% 0.00%
Lumos Pharma Inc 0.00% 0.00% 0.00% 0.00%
Oncternal Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Ibio inc 0.00% 0.00% 0.00% 0.00%
Actinium Pharmaceuticals Inc 0.00% 0.00% 0.00% 0.00%
Adagene Inc 0.00% 0.01% 0.00% 0.01%
Regenerx Biopharmaceuticals inc 0.00% 0.00% 0.00% 0.00%
Merrimack Pharmaceuticals Inc 0.00% 0.04% 0.00% 0.00%
Rein Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Corvus Pharmaceuticals Inc 0.00% 0.00% 0.00% 0.00%
Milestone Pharmaceuticals inc 0.00% 0.00% 0.00% 0.00%
89bio Inc 0.00% 0.00% 0.00% 0.00%
Iveric Bio Inc 0.00% 0.00% 0.00% 0.00%
Kinnate Biopharma Inc 0.00% 0.00% 0.00% 0.00%
Terns Pharmaceuticals Inc 0.00% 0.00% 0.00% 0.00%
Mira Pharmaceuticals Inc 0.00% 0.00% 0.00% 0.00%
Inhibitor Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Palvella Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Tyme Technologies Inc. 0.00% 0.00% 0.00% 0.00%
Nucana Plc 0.00% 0.00% 0.00% 0.00%
Effector Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Paxmedica Inc 0.00% 0.00% 0.00% 0.00%
Neubase Therapeutics inc 0.00% 0.00% 0.00% 0.00%
Phio Pharmaceuticals Corp 0.00% 0.00% 0.00% 0.00%
Nextcure Inc 0.00% 0.00% 0.00% 0.00%
Whitehawk Therapeutics Inc 0.00% 0.00% 0.01% 0.00%
Kineta Inc 0.00% 0.00% 0.00% 0.00%
Tempest Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Enliven Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
SUBTOTAL 100% 100% 100% 100%



MNPR's Market share relative to its competitors, as of Q1 2025 within the Healthcare Sector
As of Q1 2025



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2025		 MARKET SHARE
12 Months Ending
Q4 2024		 MARKET SHARE
MRQ
Q1 2025		 MARKET SHARE

Q4 2024
Monopar Therapeutics Inc 0.00% 0.00% 0.00 % 0.00 %
Merck and Co Inc 18.83% 18.93% 18.77% 17.66%
Abbvie Inc 16.90% 16.62% 16.13% 17.07%
Eli Lilly And Company 14.43% 13.29% 15.38% 15.30%
Bristol myers Squibb Company 14.03% 14.25% 13.54% 13.95%
Novartis Ag 13.74% 15.29% 13.74% 15.29%
Astrazeneca Plc 13.49% 13.08% 13.49% 13.08%
Regeneron Pharmaceuticals Inc 4.15% 4.19% 3.66% 4.28%
Vertex Pharmaceuticals Inc 3.27% 3.25% 3.35% 3.29%
Lantheus Holdings Inc 0.45% 0.45% 0.45% 0.44%
Supernus Pharmaceuticals inc 0.20% 0.20% 0.18% 0.20%
Madrigal Pharmaceuticals Inc 0.09% 0.00% 0.17% 0.12%
Intercept Pharmaceuticals inc 0.08% 0.08% 0.11% 0.09%
Deciphera Pharmaceuticals Inc 0.05% 0.05% 0.05% 0.05%
Macrogenics Inc 0.05% 0.04% 0.02% 0.02%
Rhythm Pharmaceuticals inc 0.04% 0.04% 0.04% 0.05%
Wave Life Sciences Ltd 0.03% 0.03% 0.01% 0.09%
Alimera Sciences Inc 0.03% 0.03% 0.03% 0.03%
Zymeworks Inc 0.03% 0.02% 0.03% 0.04%
Y mabs Therapeutics inc 0.03% 0.03% 0.03% 0.03%
Adc Therapeutics Sa 0.02% 0.04% 0.02% 0.02%
Nurix Therapeutics Inc 0.02% 0.02% 0.02% 0.02%
Xoma Royalty Corporation 0.01% 0.01% 0.02% 0.01%
Mersana Therapeutics inc 0.01% 0.01% 0.00% 0.02%
Pliant Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Affimed N v 0.00% 0.01% 0.00% 0.01%
Aravive Inc 0.00% 0.00% 0.00% 0.00%
Chinook Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Adlai Nortye Ltd 0.00% 0.00% 0.00% 0.00%
Salarius Pharmaceuticals inc 0.00% 0.00% 0.00% 0.00%
Nuvalent Inc 0.00% 0.00% 0.00% 0.00%
I mab 0.00% 0.00% 0.00% 0.00%
Bolt Biotherapeutics Inc 0.00% 0.00% 0.00% 0.00%
Reata Pharmaceuticals Inc 0.00% 0.00% 0.03% 0.00%
Oramed Pharmaceuticals Inc 0.00% 0.00% 0.00% 0.00%
Infinity Pharmaceuticals Inc 0.00% 0.00% 0.00% 0.00%
Lumos Pharma Inc 0.00% 0.00% 0.00% 0.00%
Oncternal Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Ibio inc 0.00% 0.00% 0.00% 0.00%
Actinium Pharmaceuticals Inc 0.00% 0.00% 0.00% 0.00%
Adagene Inc 0.00% 0.01% 0.00% 0.01%
Regenerx Biopharmaceuticals inc 0.00% 0.00% 0.00% 0.00%
Merrimack Pharmaceuticals Inc 0.00% 0.04% 0.00% 0.00%
Rein Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Corvus Pharmaceuticals Inc 0.00% 0.00% 0.00% 0.00%
Milestone Pharmaceuticals inc 0.00% 0.00% 0.00% 0.00%
89bio Inc 0.00% 0.00% 0.00% 0.00%
Iveric Bio Inc 0.00% 0.00% 0.00% 0.00%
Kinnate Biopharma Inc 0.00% 0.00% 0.00% 0.00%
Terns Pharmaceuticals Inc 0.00% 0.00% 0.00% 0.00%
Mira Pharmaceuticals Inc 0.00% 0.00% 0.00% 0.00%
Inhibitor Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Palvella Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Tyme Technologies Inc. 0.00% 0.00% 0.00% 0.00%
Nucana Plc 0.00% 0.00% 0.00% 0.00%
Effector Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Paxmedica Inc 0.00% 0.00% 0.00% 0.00%
Neubase Therapeutics inc 0.00% 0.00% 0.00% 0.00%
Phio Pharmaceuticals Corp 0.00% 0.00% 0.00% 0.00%
Nextcure Inc 0.00% 0.00% 0.00% 0.00%
Whitehawk Therapeutics Inc 0.00% 0.00% 0.01% 0.00%
Kineta Inc 0.00% 0.00% 0.00% 0.00%
Tempest Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Enliven Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
SUBTOTAL 100% 100% 100% 100%



Note: Market share is calculated based on total revenue. To get a more accurate picture of Monopar Therapeutics Inc's market divisions, geographic dispersion, segments, products, and services, visit Monopar Therapeutics Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright � 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com